OB/Gyn
Breast Cancer
More in Breast Cancer
Lack of biomarkers handicaps decision making in era of expanding treatment options
No improvement in survival or impact on recurrence, but pending studies leave door ajar
Study was stopped early due to enrollment issues, but lessons can still be learned
Significant improvement in 5-year distant relapse-free interval with higher risk score
Radiotherapy also resulted in fewer treatment-related adverse events
Nearly identical 5-year outcomes with no surgery, sentinel lymph node biopsy
Study results are "historic," expert says
Lower rates of mortality and cancer recurrence with mastectomy, salpingo-oophorectomy
No invasive cancer increase at 2 years, but editorialists say data don't back active monitoring
However, imlunestrant failed to improve PFS among entire trial population
Overall cancer detection rate was about 43% higher versus women who chose not to participate
Prevention and screening efforts accounted for 80% of those averted deaths
Nearly half of women with unusual or nonreportable cfDNA-sequencing results had cancer
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
